HealthEquity, Inc. (HQY) Reaches $76.94 52-Week High; Boston Partners Has Decreased Landec (LNDC) Holding By $301,680

May 27, 2018 - By Sheldon Barnett

HealthEquity, Inc. (NASDAQ:HQY) Logo

Boston Partners decreased Landec Corp (LNDC) stake by 6.16% reported in 2017Q4 SEC filing. Boston Partners sold 25,140 shares as Landec Corp (LNDC)’s stock rose 5.31%. The Boston Partners holds 383,245 shares with $4.83 million value, down from 408,385 last quarter. Landec Corp now has $387.28 million valuation. The stock increased 1.81% or $0.25 during the last trading session, reaching $14.05. About 19,156 shares traded. Landec Corporation (NASDAQ:LNDC) has risen 11.69% since May 27, 2017 and is uptrending. It has outperformed by 0.14% the S&P500.

The stock of HealthEquity, Inc. (NASDAQ:HQY) hit a new 52-week high and has $79.25 target or 3.00% above today’s $76.94 share price. The 9 months bullish chart indicates low risk for the $4.75 billion company. The 1-year high was reported on May, 27 by Barchart.com. If the $79.25 price target is reached, the company will be worth $142.62M more. The stock increased 1.62% or $1.23 during the last trading session, reaching $76.94. About 276,828 shares traded. HealthEquity, Inc. (NASDAQ:HQY) has risen 49.52% since May 27, 2017 and is uptrending. It has outperformed by 37.97% the S&P500.

More news for HealthEquity, Inc. (NASDAQ:HQY) were recently published by: Seekingalpha.com, which released: “Premarket analyst action – healthcare” on May 23, 2018. Nasdaq.com‘s article titled: “HealthEquity Sets Date to Announce First Quarter Results Fiscal Year 2019” and published on May 14, 2018 is yet another important article.

HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company has market cap of $4.75 billion. The Company’s services and products include healthcare saving and spending platform, a cloud platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It has a 99.92 P/E ratio. The firm also offers online-only investment advisory services through HealthEquity Advisor, a Web tool; and healthcare incentives that enable its employer partners and health plan partners to offer, and its members to earn, financial incentives for participation in wellness programs.

Analysts await HealthEquity, Inc. (NASDAQ:HQY) to report earnings on June, 5. They expect $0.22 EPS, up 15.79% or $0.03 from last year’s $0.19 per share. HQY’s profit will be $13.59M for 87.43 P/E if the $0.22 EPS becomes a reality. After $0.06 actual EPS reported by HealthEquity, Inc. for the previous quarter, Wall Street now forecasts 266.67% EPS growth.

Among 16 analysts covering HealthEquity Inc (NASDAQ:HQY), 14 have Buy rating, 0 Sell and 2 Hold. Therefore 88% are positive. HealthEquity Inc has $8300 highest and $27 lowest target. $58.93’s average target is -23.41% below currents $76.94 stock price. HealthEquity Inc had 45 analyst reports since August 18, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Monday, March 26. The firm earned “Neutral” rating on Wednesday, September 7 by Robert W. Baird. Cantor Fitzgerald maintained HealthEquity, Inc. (NASDAQ:HQY) rating on Wednesday, July 5. Cantor Fitzgerald has “Buy” rating and $5500 target. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, August 28. The stock of HealthEquity, Inc. (NASDAQ:HQY) earned “Buy” rating by Suntrust Robinson on Wednesday, June 8. JP Morgan maintained the stock with “Overweight” rating in Tuesday, April 24 report. The firm earned “Hold” rating on Tuesday, September 19 by Robert W. Baird. The company was maintained on Tuesday, March 20 by Robert W. Baird. The rating was maintained by KeyBanc Capital Markets with “Buy” on Wednesday, October 11. The company was maintained on Friday, November 3 by Robert W. Baird.

Boston Partners increased Orion Group Holdings Inc (NYSE:ORN) stake by 694,395 shares to 1.85M valued at $14.45M in 2017Q4. It also upped Loews Corp (NYSE:L) stake by 131,148 shares and now owns 8.05 million shares. Pq Group Hldgs Inc was raised too.

Another recent and important Landec Corporation (NASDAQ:LNDC) news was published by Globenewswire.com which published an article titled: “Landec Corporation to Nominate Two New Board Directors” on May 24, 2018.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.25, from 1.08 in 2017Q3. It fall, as 8 investors sold LNDC shares while 32 reduced holdings. 10 funds opened positions while 23 raised stakes. 25.41 million shares or 0.60% less from 25.56 million shares in 2017Q3 were reported. Stone Ridge Asset holds 0.03% or 32,169 shares in its portfolio. Renaissance Technologies Lc owns 15,000 shares or 0% of their US portfolio. Legal And General Grp Pcl has 0% invested in Landec Corporation (NASDAQ:LNDC). Blackrock holds 0% or 1.87M shares. Heartland holds 848,550 shares. Metropolitan Life Insur New York has 0% invested in Landec Corporation (NASDAQ:LNDC) for 9,543 shares. Northern Trust owns 354,468 shares. Deutsche Natl Bank Ag holds 0% or 60,779 shares in its portfolio. Ancora Advisors Lc stated it has 103,595 shares or 0.07% of all its holdings. Schwab Charles Invest Mngmt has 117,389 shares. Palouse Cap Mgmt reported 16,494 shares. Cadence Cap Management Ltd Co holds 0.04% or 52,820 shares in its portfolio. Kennedy Management reported 111,886 shares or 0.03% of all its holdings. 263,142 were accumulated by Pacific Ridge Cap Prns Limited Liability Company. Ny State Common Retirement Fund accumulated 113,563 shares.

Since April 6, 2018, it had 0 insider purchases, and 5 insider sales for $412,561 activity. Midyett Ronald Lane had sold 4,631 shares worth $64,256.

Among 4 analysts covering Landec (NASDAQ:LNDC), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Landec had 7 analyst reports since November 18, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, June 7 by Maxim Group. Maxim Group maintained it with “Buy” rating and $1800 target in Wednesday, July 26 report. On Monday, January 25 the stock rating was upgraded by Sidoti to “Buy”. The stock has “Buy” rating by Maxim Group on Tuesday, July 18. The firm has “Hold” rating by Wedbush given on Wednesday, July 26. The company was initiated on Wednesday, November 18 by Wunderlich. Wedbush initiated the shares of LNDC in report on Friday, July 8 with “Neutral” rating.

Analysts await Landec Corporation (NASDAQ:LNDC) to report earnings on July, 24. They expect $0.22 EPS, up 144.44% or $0.13 from last year’s $0.09 per share. LNDC’s profit will be $6.06M for 15.97 P/E if the $0.22 EPS becomes a reality. After $0.09 actual EPS reported by Landec Corporation for the previous quarter, Wall Street now forecasts 144.44% EPS growth.

Landec Corporation (NASDAQ:LNDC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: